---
figid: PMC7658374__fmolb-07-575608-g001
figlink: pmc/articles/PMC7658374/figure/F1/
number: F1
caption: The TGF beta SMAD-dependent signaling pathway. The diagram shows some of
  the major components of the TGFβ signaling pathway. SMAD-dependents signal transduction
  is initiated with the binding of the ligands (e.g., TGFβ, BMP, activins etc.) to
  the serine/threonine type II receptor that phosphorylates and activates the type
  I receptor which causes dimerization of the type II and type I receptors in a heterotetrameric
  complex. The signal is then propagated to the nucleus through phosphorylation of
  SMAD transcription factors. The image represents only few of the ligands/receptors/SMADs
  possible signal transduction combinations.
pmcid: PMC7658374
papertitle: 'Endoplasmic Reticulum Associated Protein Degradation (ERAD) in the Pathology
  of Diseases Related to TGFβ Signaling Pathway: Future Therapeutic Perspectives.'
reftext: Nesrin Gariballa, et al. Front Mol Biosci. 2020;7:575608.
pmc_ranked_result_index: '20432'
pathway_score: 0.9517053
filename: fmolb-07-575608-g001.jpg
figtitle: TGF beta SMAD-dependent signaling pathway
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7658374__fmolb-07-575608-g001.html
  '@type': Dataset
  description: The TGF beta SMAD-dependent signaling pathway. The diagram shows some
    of the major components of the TGFβ signaling pathway. SMAD-dependents signal
    transduction is initiated with the binding of the ligands (e.g., TGFβ, BMP, activins
    etc.) to the serine/threonine type II receptor that phosphorylates and activates
    the type I receptor which causes dimerization of the type II and type I receptors
    in a heterotetrameric complex. The signal is then propagated to the nucleus through
    phosphorylation of SMAD transcription factors. The image represents only few of
    the ligands/receptors/SMADs possible signal transduction combinations.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - INHBA
  - INHBB
  - BMPR2
  - ACVR1
  - BMPR1A
  - BMPR1B
  - ACVR2A
  - TGFBR2
  - ACVR1B
  - SMAD1
  - SMAD2
  - SMAD5
  - SMAD6
  - SMAD9
  - SMAD3
  - SMAD4
  - SMAD7
genes:
- word: Activins
  symbol: Activin
  source: bioentities_symbol
  hgnc_symbol: INHBA
  entrez: '3624'
- word: Activins
  symbol: Activin
  source: bioentities_symbol
  hgnc_symbol: INHBB
  entrez: '3625'
- word: BMPR2
  symbol: BMPR2
  source: hgnc_symbol
  hgnc_symbol: BMPR2
  entrez: '659'
- word: ALK2
  symbol: ALK2
  source: hgnc_alias_symbol
  hgnc_symbol: ACVR1
  entrez: '90'
- word: ALK3
  symbol: ALK3
  source: hgnc_alias_symbol
  hgnc_symbol: BMPR1A
  entrez: '657'
- word: ALK6
  symbol: ALK6
  source: hgnc_alias_symbol
  hgnc_symbol: BMPR1B
  entrez: '658'
- word: ACVR2A
  symbol: ACVR2A
  source: hgnc_symbol
  hgnc_symbol: ACVR2A
  entrez: '92'
- word: TGFBR2
  symbol: TGFBR2
  source: hgnc_symbol
  hgnc_symbol: TGFBR2
  entrez: '7048'
- word: Alk4
  symbol: ALK4
  source: hgnc_alias_symbol
  hgnc_symbol: ACVR1B
  entrez: '91'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD1
  entrez: '4086'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD5
  entrez: '4090'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD6
  entrez: '4091'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD9
  entrez: '4093'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD7
  entrez: '4092'
chemicals: []
diseases: []
figid_alias: PMC7658374__F1
redirect_from: /figures/PMC7658374__F1
figtype: Figure
---
